National Commercial and Medicare Part D formulary coverage under the pharmacy benefit as of April 2024 in AD.2
COMMITTED
TO EXCEPTIONAL ACCESS
Help your appropriate patients get started on RINVOQ Complete by downloading these important access forms.
Help enroll your patients in
Complete and send the enrollment and prescription form to the patient's specialty pharmacy and to RINVOQ Complete. Once enrolled, patients can get access to
RINVOQ Complete Rebate: Eligible, commercially insured patients may pay as little as $0 on the cost of required lab tests and monitoring, per lab test visit‡
1-to-1 support from Insurance Specialists and Nurse Ambassadors§
RINVOQ Complete Bridging Resource: No-cost option for eligible, commercially insured RINVOQ patients enables earliest treatment start||
As with all no-charge programs, considerations include:
- Fixed program duration¶
- Ongoing prior authorizations and appeals to maintain eligibility
- Program-mandated distribution process
§Nurse Ambassadors are provided by AbbVie and do not provide medical advice or work under the direction of the prescribing health care professional (HCP). They are trained to direct patients to speak with their HCP about any treatment-related questions, including further referrals.
Check the Formulary Status for RINVOQ in Your Area
Formulary Zipcode
Select a filter
Choose Indication
Formulary Status Results
- Plan Name
- Plan Type
- Status
Results ends here
Preferred means RINVOQ is on a preferred tier or otherwise has preferred status on the plan’s formulary.
Additional resources are available to support your patients in accessing and receiving treatment with RINVOQ
*RINVOQ is on a preferred tier or otherwise has preferred status on the plan’s formulary.
†Coverage requirements and benefit designs vary by payer and may change over time. Please consult with payers directly for the most current reimbursement policies.
‡Eligibility: Available to patients with commercial insurance coverage for RINVOQ who meet eligibility criteria. This co-pay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law. Offer subject to change or termination without notice. Restrictions, including monthly maximums, may apply. This is not health insurance. For full Terms and Conditions, visit RINVOQSavingsCard.com or call 1.800.2RINVOQ for additional information. To learn about AbbVie’s privacy practices and your privacy choices, visit https://privacy.abbvie
||Eligibility criteria: Available to patients aged 63 or younger with commercial insurance coverage. Patients must have a valid prescription for RINVOQ for an FDA approved indication and a denial of insurance coverage based on a prior authorization request on file along with a confirmation of appeal. Continued eligibility for the program requires the submission of an appeal of the coverage denial every 180 days. Program provides for RINVOQ at no charge to patients for up to two years or until they receive insurance coverage approval, whichever occurs earlier, and is not contingent on purchase requirements of any kind. Program is not available to patients whose medications are reimbursed in whole or in part by Medicare, Medicaid, TRICARE, or any other federal or state program. Offer subject to change or discontinuance without notice. This is not health insurance and program does not guarantee insurance coverage. No claims for payment may be submitted to any third party for product dispensed by program. Limitations may apply.
¶Program duration may be limited by manufacturer terms and conditions.